|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Venerito M, Vasapolli R, Rokkas T and
Malfertheiner P: Gastric cancer: Epidemiology, prevention, and
therapy. Helicobacter. 23 (Suppl 1):e125182018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marin JJ, Al-Abdulla R, Lozano E, Briz O,
Bujanda L, Banales JM and Macias RI: Mechanisms of resistance to
chemotherapy in gastric cancer. Anticancer Agents Med Chem.
16:318–334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun J, Du N, Li J, Zhou J, Tao G, Sun S
and He J: Transcription factor AP2epsilon: A potential predictor of
chemoresistance in patients with gastric cancer. Technol Cancer Res
Treat. 15:285–295. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tummala R, Romano RA, Fuchs E and Sinha S:
Molecular cloning and characterization of AP-2 epsilon, a fifth
member of the AP-2 family. Gene. 321:93–102. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chhabra R: miRNA and methylation: A
multifaceted liaison. Chembiochem. 16:195–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Keller S, Sanderson MP, Stoeck A and
Altevogt P. Exosomes: From biogenesis and secretion to biological
function. Immunol Lett. 107:102–108. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brinton LT, Sloane HS, Kester M and Kelly
KA: Formation and role of exosomes in cancer. Cell Mol Life Sci.
72:659–671. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Niel G, Porto-Carreiro I, Simoes S and
Raposo G: Exosomes: A common pathway for a specialized function. J
Biochem. 140:13–21. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Toiyama Y, Okugawa Y and Goel A: DNA
methylation and microRNA biomarkers for noninvasive detection of
gastric and colorectal cancer. Biochem Biophys Res Commun.
455:43–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao B, Bian EB and Li J and Li J: New
advances of microRNAs in glioma stem cells, with special emphasis
on aberrant methylation of microRNAs. J Cell Physiol.
229:1141–1147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Anwar SL and Lehmann U: DNA methylation,
microRNAs, and their crosstalk as potential biomarkers in
hepatocellular carcinoma. World J Gastroenterol. 20:7894–7913.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang H, Zeng L, Wang J, Zhang X, Ruan Q,
Wang J, Cui S and Yang D: Reversal of 5-fluorouracil resistance by
EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway
and down-regulation of MDR-1 and P-gp expression in gastric cancer.
Oncotarget. 8:82842–82853. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeringer E, Barta T, Li M and Vlassov AV:
Strategies for isolation of exosomes. Cold Spring Harb Protoc.
2015:319–323. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Giovannetti E, Codacci-Pisanelli G and
Peters GJ: TFAP2E-DKK4 and chemoresistance in colorectal cancer. N
Engl J Med. 366:9662012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feng D, Ma Y, Liu J, Xu L, Zhang Y, Qu J,
Liu Y and Qu X: Cbl-b enhances sensitivity to 5-fluorouracil via
EGFR- and mitochondria-mediated pathways in gastric cancer cells.
Int J Mol Sci. 14:24399–24411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tahara M, Ochiai A, Fujimoto J, Boku N,
Yasui W, Ohtsu A, Tahara E and Yoshida S: Expression of thymidylate
synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase,
E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric
cancer patients treated with bolus 5-fluorouracil. Oncol Rep.
11:9–15. 2004.PubMed/NCBI
|
|
18
|
Peng Z, Li Z, Gao J, Lu M, Gong J, Tang
ET, Oliner KS, Hei YJ, Zhou H and Shen L: Tumor MET expression and
gene amplification in chinese patients with locally advanced or
metastatic gastric or gastroesophageal junction cancer. Mol Cancer
Ther. 14:2634–2641. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei Z, Jiang X, Liu F, Qiao H, Zhou B,
Zhai B, Zhang L, Zhang X, Han L, Jiang H, et al: Downregulation of
Skp2 inhibits the growth and metastasis of gastric cancer cells in
vitro and in vivo. Tumour Biol. 34:181–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Piro G, Carbone C, Cataldo I, Di
Nicolantonio F, Giacopuzzi S, Aprile G, Simionato F, Boschi F,
Zanotto M, Mina MM, et al: An FGFR3 autocrine loop sustains
acquired resistance to trastuzumab in gastric cancer patients. Clin
Cancer Res. 22:6164–6175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen F, Zhuang M, Zhong C, Peng J, Wang X,
Li J, Chen Z and Huang Y: Baicalein reverses hypoxia-induced 5-FU
resistance in gastric cancer AGS cells through suppression of
glycolysis and the PTEN/Akt/HIF-1α signaling pathway. Oncol Rep.
33:457–463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun Y, Jiang Y, Huang J, Chen H, Liao Y
and Yang Z: CISD2 enhances the chemosensitivity of gastric cancer
through the enhancement of 5-FU-induced apoptosis and the
inhibition of autophagy by AKT/mTOR pathway. Cancer Med.
6:2331–2346. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiong HL, Zhou SW, Sun AH, He Y, Li J and
Yuan X: MicroRNA197 reverses the drug resistance of
fluorouracilinduced SGC7901 cells by targeting mitogenactivated
protein kinase 1. Mol Med Rep. 12:5019–5025. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang WK, Lee I and Park C:
Characterization of RhoA-mediated chemoresistance in gastric cancer
cells. Cancer Res Treat. 37:251–256. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu GY and Tang XJ: Troxerutin (TXN)
potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer
through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
Biomed Pharmacother. 92:95–107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
To KF, Chan MW, Leung WK, Ng EK, Yu J, Bai
AH, Lo AW, Chu SH, Tong JH, Lo KW, et al: Constitutional activation
of IL-6-mediated JAK/STAT pathway through hypermethylation of
SOCS-1 in human gastric cancer cell line. Br J Cancer.
91:1335–1341. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang X, Yuan X, Shi H, Wu L, Qian H and
Xu W: Exosomes in cancer: Small particle, big player. J Hematol
Oncol. 8:332015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Seelan RS, Mukhopadhyay P, Pisano MM and
Greene RM: Effects of 5-Aza-2′-deoxycytidine (decitabine) on gene
expression. Drug Metab Rev. 50:193–207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hong Y, Zhang J, Zhuang M, Li W, Wu P, Li
R, Hu N, Bian B, Song Z and Wu F: Efficacy of decitabine-loaded
gelatinases-stimuli nanoparticles in overcoming cancer drug
resistance is mediated via its enhanced demethylating activity to
transcription factor AP-2 epsilon. Oncotarget. 8:114495–114505.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie
G, Ma Y and Shen L: Exosomal transfer of tumor-associated
macrophage-derived miR-21 confers cisplatin resistance in gastric
cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matsuzaki T, Yashiro M, Kaizaki R, Yasuda
K, Doi Y, Sawada T, Ohira M and Hirakawa K: Synergistic
antiproliferative effect of mTOR inhibitors in combination with
5-fluorouracil in scirrhous gastric cancer. Cancer Sci.
100:2402–2410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hajimoradi M, Mohammad Hassan Z, Ebrahimi
M, Soleimani M, Bakhshi M, Firouzi J and Samani FS: STAT3 is
overactivated in gastric cancer stem-like cells. Cell J.
17:617–628. PubMed/NCBI
|
